ANGO 外汇新闻
AngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlook
While reporting financial results for the third quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) slashed its adjusted loss and net sales guidance for the full year 2024, reflecting the recent divestiture of the PICC and Midline businesses and discontinuance of the RadioFrequency ablation and Syntrax businesses.
RTTNews
|
288天前
AngioDynamics Q2 Results Miss Estimates; Boosts FY24 Adj. EPS Outlook
While reporting financial results for the second quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) raised its adjusted earnings guidance for the full year 2024, while trimming annual net sales outlook.
RTTNews
|
378天前
AngioDynamics Q1 Results Miss Estimates; Reaffirms FY23 Outlook
While reporting financial results for the first quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) reaffirmed its adjusted earnings and net sales guidance for the full year 2023.
RTTNews
|
834天前
